Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2022 08:30 ET | Source: SurgePays, Inc.

SurgePays, Inc Announces Upcoming Investor Conference Participation

BARTLETT, Tenn., April 13, 2022 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecommunications company focused on the underbanked and...
April 13, 2022 08:30 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Deprioritizes Development of ONCT-216 to Focus Resources on Phase 3 Trial for Zilovertamab in the Treatment of Mantle Cell Lymphoma

Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcomaResources will be primarily reallocated to our zilovertamab global registrational Phase 3 study ZILO-301, which is expected to be...
April 13, 2022 08:30 ET | Source: ChemoCentryx, Inc.

ChemoCentryx Reports Pharmacokinetic and Pharmacodynamic Results from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at American Association for Cancer Research (AACR) Annual Meeting 2022

-- Human pharmacokinetics (PK) reveal CCX559 exposure tracking with projections, with good oral availability and expected half-life -- -- Pharmacodynamic (PD) results show CCX559 exhibits immune...
April 13, 2022 08:30 ET | Source: IN8bio, Inc

IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key Appointments

Urvashi Patel, Ph.D., as Vice President, Regulatory AffairsStacey Bilinski, as Vice President, Clinical Operations NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a...
April 13, 2022 08:30 ET | Source: Alico, Inc.

Alico, Inc. to Attend the Noble Capital Markets’ Eighteenth Annual Investor Conference

FORT MYERS, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that Richard Rallo, the Company’s Senior Vice President and Chief Financial...
April 13, 2022 08:30 ET | Source: Nuvectis Pharma, Inc.

Nuvectis Pharma Recaps Poster Presentation Highlights for NXP900 at the 2022 American Association for Cancer Research (AACR) Conference

Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis” or the “Company”), a biopharmaceutical company focused on the development of precision medicines for...
April 13, 2022 08:30 ET | Source: Artelo Biosciences

Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia

SOLANA BEACH, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...
April 13, 2022 08:30 ET | Source: EMCORE Corporation

EMCORE Awarded Medallion 8100 L-EML™ Transmitter Contract Extension for Multi-Year Project in Europe

ALHAMBRA, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense, communications,...
April 13, 2022 08:20 ET | Source: Pineapple Energy

Pineapple Holdings, Inc. Changes Legal Name to Pineapple Energy Inc.

MINNETONKA, Minn., April 13, 2022 (GLOBE NEWSWIRE) -- Pineapple Holdings, Inc., which was formerly Communications Systems, Inc. and changed its name when completing the merger with Pineapple Energy...
April 13, 2022 08:19 ET | Source: Calavo Growers, Inc.

Calavo Growers, Inc. Announces Business Reorganization

SANTA PAULA, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW) (“Calavo” or the “Company”), a global avocado-industry leader and provider of value-added fresh food,...